MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study
Study on the Effect of Mono-Unsaturated Fatty Acids (MUFA) and the Mediterranean Diet on Hyperinsulinemia and Other Components of the Metabolic Syndrome
1 other identifier
interventional
60
1 country
2
Brief Summary
Background: During the 1990s, the prevalence of the metabolic syndrome in the Netherlands ranged from 3% in women of 20-39 yrs to at least 33% in men 55 yrs and older and it is expected to increasing. Prevention is therefore warranted. In this respect the amount and type of fat in the diet deserves attention. Recently, an intervention study reported that a diet high in mono-unsaturated fatty acids (MUFA) such as from olive oil, increased insulin sensitivity in healthy subjects. However, additional beneficial effects can be expected from the Mediterranean diet as a whole. Hypothesis: Replacing saturated fatty acids (SFA) by mono-unsaturated fatty acids (MUFA) will improve hyperinsulinemia and dyslipidemia, and a typical Mediterranean diet will even have more pronounced effects. Study objectives: To investigate the impact of the Mediterranean diet, and especially the intake of MUFA, on markers of the metabolic syndrome in high-risk subjects. Methods: The controlled dietary intervention will include 60 subjects aged 40-65 years with moderate abdominal obesity. After a run-in diet for 2 weeks they will be assigned randomly to receive one of the three diets for a period of 8 weeks. Measurements of serum insulin concentration and other parameters will be carried out at weeks 2 and 10. Expected results: Our study will provide information on the role of MUFA and the expected beneficial impact of other factors of the Mediterranean type of diet on the metabolic syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2006
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 28, 2006
CompletedFirst Posted
Study publicly available on registry
November 29, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedDecember 12, 2007
December 1, 2007
November 28, 2006
December 10, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fasting Insulin
Secondary Outcomes (10)
Systolic/ diastolic blood pressure
plasma glucose
serum HDL-cholesterol
serum triglycerides
waist-hip circumference
- +5 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Waist circumference ≥ 94 cm for men or ≥ 80 cm for women
- Age from 40 to 65 years at the time of randomisation
- Written informed consent obtained
You may not qualify if:
- Unable or unwilling to comply with study procedures.
- The use of drugs for lowering serum cholesterol, serum triglycerides, blood pressure, or diabetes.
- Unusual dietary patterns, including high alcohol intakes
- Recent (\< 4 weeks) or current participation in a study with any investigational drug or dietary intervention.
- High concentrations of total cholesterol (\>8 mmol/L).
- Diabetes mellitus.
- Being pregnant or giving breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wageningen Universitylead
- Netherlands Heart Foundationcollaborator
- Unilever R&Dcollaborator
Study Sites (2)
Hospital Gelderse Vallei
Ede, 6710 HN, Netherlands
Wageningen University, Division of Human Nutrition
Wageningen, Netherlands
Related Publications (6)
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004 Sep 22;292(12):1440-6. doi: 10.1001/jama.292.12.1440.
PMID: 15383514BACKGROUNDVessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH; KANWU Study. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001 Mar;44(3):312-9. doi: 10.1007/s001250051620.
PMID: 11317662BACKGROUNDPanagiotakos DB, Polychronopoulos E. The role of Mediterranean diet in the epidemiology of metabolic syndrome; converting epidemiology to clinical practice. Lipids Health Dis. 2005 Apr 12;4:7. doi: 10.1186/1476-511X-4-7.
PMID: 15826300BACKGROUNDSerra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev. 2006 Feb;64(2 Pt 2):S27-47. doi: 10.1111/j.1753-4887.2006.tb00232.x.
PMID: 16532897BACKGROUNDvan Dijk SJ, Feskens EJ, Bos MB, de Groot LC, de Vries JH, Muller M, Afman LA. Consumption of a high monounsaturated fat diet reduces oxidative phosphorylation gene expression in peripheral blood mononuclear cells of abdominally overweight men and women. J Nutr. 2012 Jul;142(7):1219-25. doi: 10.3945/jn.111.155283. Epub 2012 May 23.
PMID: 22623392DERIVEDvan Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG, de Groot LC, de Vries JH, Muller M, Afman LA. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr. 2009 Dec;90(6):1656-64. doi: 10.3945/ajcn.2009.27792. Epub 2009 Oct 14.
PMID: 19828712DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edith JM Feskens, Dr.
Division of Human Nutrition, Wageningen University
- PRINCIPAL INVESTIGATOR
Jeanne HM de Vries, Dr.
Division of Human Nutrition, Wageningen University
- PRINCIPAL INVESTIGATOR
Lisette CP de Groot, Prof.
Division of Human Nutrition, Wageningen University
- PRINCIPAL INVESTIGATOR
Lydia A. Afman, Dr.
Division of Human Nutrition, Wageningen University
- PRINCIPAL INVESTIGATOR
Michael R. Muller, Prof.
Division of Human Nutrition, Wageningen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 28, 2006
First Posted
November 29, 2006
Study Start
November 1, 2006
Study Completion
April 1, 2007
Last Updated
December 12, 2007
Record last verified: 2007-12